<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0&amp;ff=20240212011100&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0&amp;ff=20240212011100&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0)</generator>
<language>en</language>
<lastbuilddate>Mon, 12 Feb 2024 06:11:01 +0000</lastbuilddate>
<pubDate>Sat, 10 Feb 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Rising stars in cardiology: Floris Heinen, MD</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38340018/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 10:ehae077. doi: 10.1093/eurheartj/ehae077. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38340018/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38340018</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae077>10.1093/eurheartj/ehae077</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38340018</guid>
<pubDate>Sat, 10 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Judith Ozkan</dc:creator>
<dc:date>2024-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Rising stars in cardiology: Floris Heinen, MD</dc:title>
<dc:identifier>pmid:38340018</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae077</dc:identifier>
</item>
<item>
<title>The obesity syndemic in the European community: towards a systems thinking approach for preventive policies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38339964/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 10:ehae066. doi: 10.1093/eurheartj/ehae066. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38339964/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38339964</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae066>10.1093/eurheartj/ehae066</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38339964</guid>
<pubDate>Sat, 10 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Gema Frühbeck</dc:creator>
<dc:creator>Luca Busetto</dc:creator>
<dc:creator>Federico Carbone</dc:creator>
<dc:date>2024-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The obesity syndemic in the European community: towards a systems thinking approach for preventive policies</dc:title>
<dc:identifier>pmid:38339964</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae066</dc:identifier>
</item>
<item>
<title>Cardiac cryptographers: cracking the code of the epitranscriptome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38339963/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 10:ehae057. doi: 10.1093/eurheartj/ehae057. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38339963/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38339963</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae057>10.1093/eurheartj/ehae057</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38339963</guid>
<pubDate>Sat, 10 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Charles P Rabolli</dc:creator>
<dc:creator>Federica Accornero</dc:creator>
<dc:date>2024-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardiac cryptographers: cracking the code of the epitranscriptome</dc:title>
<dc:identifier>pmid:38339963</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae057</dc:identifier>
</item>
<item>
<title>Advancing cardiovascular research: Gemma Vilahur talks about her pioneering heart health discoveries</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38339914/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 10:ehae034. doi: 10.1093/eurheartj/ehae034. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38339914/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38339914</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae034>10.1093/eurheartj/ehae034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38339914</guid>
<pubDate>Sat, 10 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Judith Ozkan</dc:creator>
<dc:date>2024-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Advancing cardiovascular research: Gemma Vilahur talks about her pioneering heart health discoveries</dc:title>
<dc:identifier>pmid:38339914</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae034</dc:identifier>
</item>
<item>
<title>Urgent need to define unmet medical needs in cardiovascular diseases</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38339912/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 10:ehae041. doi: 10.1093/eurheartj/ehae041. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38339912/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38339912</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae041>10.1093/eurheartj/ehae041</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38339912</guid>
<pubDate>Sat, 10 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Piotr Szymański</dc:creator>
<dc:creator>Faiez Zannad</dc:creator>
<dc:creator>Thomas F Lüscher</dc:creator>
<dc:date>2024-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Urgent need to define unmet medical needs in cardiovascular diseases</dc:title>
<dc:identifier>pmid:38339912</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae041</dc:identifier>
</item>
<item>
<title>Impact of topology on the number of loops during macro-re-entrant atrial tachycardia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38339877/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 10:ehae032. doi: 10.1093/eurheartj/ehae032. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38339877/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38339877</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae032>10.1093/eurheartj/ehae032</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38339877</guid>
<pubDate>Sat, 10 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Nele Vandersickel</dc:creator>
<dc:creator>Sander Hendrickx</dc:creator>
<dc:creator>Robin Van den Abeele</dc:creator>
<dc:creator>Bjorn Verstraeten</dc:creator>
<dc:date>2024-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Impact of topology on the number of loops during macro-re-entrant atrial tachycardia</dc:title>
<dc:identifier>pmid:38339877</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae032</dc:identifier>
</item>
<item>
<title>How artificial intelligence can assist with ischaemic heart disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38339876/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 10:ehae030. doi: 10.1093/eurheartj/ehae030. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38339876/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38339876</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae030>10.1093/eurheartj/ehae030</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38339876</guid>
<pubDate>Sat, 10 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Jamol Uzokov</dc:creator>
<dc:creator>Anis Alyavi</dc:creator>
<dc:creator>Bakhromkhon Alyavi</dc:creator>
<dc:creator>Akbar Abdullaev</dc:creator>
<dc:date>2024-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>How artificial intelligence can assist with ischaemic heart disease</dc:title>
<dc:identifier>pmid:38339876</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae030</dc:identifier>
</item>
<item>
<title>Retraction of: Age-Induced Accumulation of Succinate Promotes Cardiac Fibrogenesis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38333982/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 9. doi: 10.1161/RES.0000000000000663. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38333982/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38333982</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000663>10.1161/RES.0000000000000663</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38333982</guid>
<pubDate>Fri, 09 Feb 2024 06:00:00 -0500</pubDate>
<dc:date>2024-02-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Retraction of: Age-Induced Accumulation of Succinate Promotes Cardiac Fibrogenesis</dc:title>
<dc:identifier>pmid:38333982</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000663</dc:identifier>
</item>
<item>
<title>Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38328945/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>CONCLUSIONS: Diffuse RV uptake of bone tracer on SPECT imaging is associated with poor outcomes in patients with ATTR-CM and is an independent prognostic marker at diagnosis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Feb 8. doi: 10.1161/CIRCULATIONAHA.123.066524. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The extent of myocardial bone tracer uptake with technetium pyrophosphate, hydroxymethylene diphosphonate, and 3,3-diphosphono-1,2-propanodicarboxylate in transthyretin amyloid cardiomyopathy (ATTR-CM) might reflect cardiac amyloid burden and be associated with outcome.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Consecutive patients with ATTR-CM who underwent diagnostic bone tracer scintigraphy with acquisition of whole-body planar and cardiac single-photon emission computed tomography (SPECT) images from the National Amyloidosis Centre and 4 Italian centers were included. Cardiac uptake was defined according to the Perugini classification: 0=absent cardiac uptake; 1=mild uptake less than bone; 2=moderate uptake equal to bone; and 3=high uptake greater than bone. Extent of right ventricular (RV) uptake was defined as focal (basal segment of the RV free wall only) or diffuse (extending beyond basal segment) on the basis of SPECT imaging. The primary outcome was all-cause mortality.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 1422 patients with ATTR-CM, RV uptake accompanying left ventricular uptake was identified by SPECT imaging in 100% of cases at diagnosis. Median follow-up in the whole cohort was 34 months (interquartile range, 21 to 50 months), and 494 patients died. By Kaplan-Meier analysis, diffuse RV uptake on SPECT imaging (n=936) was associated with higher all-cause mortality compared with focal (n=486) RV uptake (77.9% versus 22.1%; <i>P</i>&lt;0.001), whereas Perugini grade was not associated with survival (<i>P</i>=0.27 in grade 2 versus grade 3). On multivariable analysis, after adjustment for age at diagnosis (hazard ratio [HR], 1.03 [95% CI, 1.02-1.04]; <i>P</i>&lt;0.001), presence of the p.(V142I) TTR variant (HR, 1.42 [95% CI, 1.20-1.81]; <i>P</i>=0.004), National Amyloidosis Centre stage (each category, <i>P</i>&lt;0.001), stroke volume index (HR, 0.99 [95% CI, 0.97-0.99]; <i>P</i>=0.043), E/e' (HR, 1.02 [95% CI, 1.007-1.03]; <i>P</i>=0.004), right atrial area index (HR, 1.05 [95% CI, 1.02-1.08]; <i>P</i>=0.001), and left ventricular global longitudinal strain (HR, 1.06 [95% CI, 1.03-1.09]; <i>P</i>&lt;0.001), diffuse RV uptake on SPECT imaging (HR, 1.60 [95% CI, 1.26-2.04]; <i>P</i>&lt;0.001) remained an independent predictor of all-cause mortality. The prognostic value of diffuse RV uptake was maintained across each National Amyloidosis Centre stage and in both wild-type and hereditary ATTR-CM (<i>P</i>&lt;0.001 and <i>P</i>=0.02, respectively).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Diffuse RV uptake of bone tracer on SPECT imaging is associated with poor outcomes in patients with ATTR-CM and is an independent prognostic marker at diagnosis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38328945/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38328945</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066524>10.1161/CIRCULATIONAHA.123.066524</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38328945</guid>
<pubDate>Thu, 08 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Aldostefano Porcari</dc:creator>
<dc:creator>Marianna Fontana</dc:creator>
<dc:creator>Marco Canepa</dc:creator>
<dc:creator>Elena Biagini</dc:creator>
<dc:creator>Francesco Cappelli</dc:creator>
<dc:creator>Christian Gagliardi</dc:creator>
<dc:creator>Simone Longhi</dc:creator>
<dc:creator>Linda Pagura</dc:creator>
<dc:creator>Giacomo Tini</dc:creator>
<dc:creator>Franca Dore</dc:creator>
<dc:creator>Rachele Bonfiglioli</dc:creator>
<dc:creator>Matteo Bauckneht</dc:creator>
<dc:creator>Alberto Miceli</dc:creator>
<dc:creator>Francesca Girardi</dc:creator>
<dc:creator>Anna Lisa Martini</dc:creator>
<dc:creator>Giulia Barbati</dc:creator>
<dc:creator>Egidio Natalino Costanzo</dc:creator>
<dc:creator>Angelo Giuseppe Caponetti</dc:creator>
<dc:creator>Andrea Paccagnella</dc:creator>
<dc:creator>Maurizio Sguazzotti</dc:creator>
<dc:creator>Giovanni La Malfa</dc:creator>
<dc:creator>Mattia Zampieri</dc:creator>
<dc:creator>Roberto Sciagrà</dc:creator>
<dc:creator>Federico Perfetto</dc:creator>
<dc:creator>Dorota Rowczenio</dc:creator>
<dc:creator>Janet Gilbertson</dc:creator>
<dc:creator>David F Hutt</dc:creator>
<dc:creator>Philip N Hawkins</dc:creator>
<dc:creator>Claudio Rapezzi</dc:creator>
<dc:creator>Marco Merlo</dc:creator>
<dc:creator>Gianfranco Sinagra</dc:creator>
<dc:creator>Julian D Gillmore</dc:creator>
<dc:date>2024-02-08</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy</dc:title>
<dc:identifier>pmid:38328945</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066524</dc:identifier>
</item>
<item>
<title>Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38328928/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>CONCLUSIONS: Our work reveals that the phosphorylation-regulated dynamic phase separation of HIP-55 protects against sympathetic/adrenergic system-mediated heart failure.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Feb 8. doi: 10.1161/CIRCULATIONAHA.123.067519. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Heart failure (HF), which is the terminal stage of many cardiovascular diseases, is associated with low survival rates and a severe financial burden. The mechanisms, especially the molecular mechanism combined with new theories, underlying the pathogenesis of HF remain elusive. We demonstrate that phosphorylation-regulated dynamic liquid-liquid phase separation of HIP-55 (hematopoietic progenitor kinase 1-interacting protein of 55 kDa) protects against HF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Fluorescence recovery after photobleaching assay, differential interference contrast analysis, pull-down assay, immunofluorescence, and immunohistochemical analysis were used to investigate the liquid-liquid phase separation capacity of HIP-55 and its dynamic regulation in vivo and in vitro. Mice with genetic deletion of HIP-55 and mice with cardiac-specific overexpression of HIP-55 were used to examine the role of HIP-55 on β-adrenergic receptor hyperactivation-induced HF. Mutation analysis and mice with specific phospho-resistant site mutagenesis were used to identify the role of phosphorylation-regulated dynamic liquid-liquid phase separation of HIP-55 in HF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Genetic deletion of HIP-55 aggravated HF, whereas cardiac-specific overexpression of HIP-55 significantly alleviated HF in vivo. HIP-55 possesses a strong capacity for phase separation. Phase separation of HIP-55 is dynamically regulated by AKT-mediated phosphorylation at S269 and T291 sites, failure of which leads to impairment of HIP-55 dynamic phase separation by formation of abnormal aggregation. Prolonged sympathetic hyperactivation stress induced decreased phosphorylation of HIP-55 S269 and T291, dysregulated phase separation, and subsequent aggregate formation of HIP55. Moreover, we demonstrated the important role of dynamic phase separation of HIP-55 in inhibiting hyperactivation of the β-adrenergic receptor-mediated P38/MAPK (mitogen-activated protein kinase) signaling pathway. A phosphorylation-deficient HIP-55 mutation, which undergoes massive phase separation and forms insoluble aggregates, loses the protective activity against HF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our work reveals that the phosphorylation-regulated dynamic phase separation of HIP-55 protects against sympathetic/adrenergic system-mediated heart failure.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38328928/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38328928</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067519>10.1161/CIRCULATIONAHA.123.067519</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38328928</guid>
<pubDate>Thu, 08 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Yunqi Jiang</dc:creator>
<dc:creator>Jinge Gu</dc:creator>
<dc:creator>Xiaodou Niu</dc:creator>
<dc:creator>Jiaojiao Hu</dc:creator>
<dc:creator>Yongzhen Zhang</dc:creator>
<dc:creator>Dan Li</dc:creator>
<dc:creator>Yida Tang</dc:creator>
<dc:creator>Cong Liu</dc:creator>
<dc:creator>Zijian Li</dc:creator>
<dc:date>2024-02-08</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure</dc:title>
<dc:identifier>pmid:38328928</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067519</dc:identifier>
</item>
<item>
<title>Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38327011/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093/eurheartj/ehae013. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38327011/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38327011</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae013>10.1093/eurheartj/ehae013</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38327011</guid>
<pubDate>Thu, 08 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Sebastian Ludwig</dc:creator>
<dc:creator>Juan F Granada</dc:creator>
<dc:date>2024-02-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward</dc:title>
<dc:identifier>pmid:38327011</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae013</dc:identifier>
</item>
<item>
<title>Digital technology and artificial intelligence for improving congenital heart disease care: alea iacta est</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38327005/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 8:ehad898. doi: 10.1093/eurheartj/ehad898. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38327005/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38327005</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad898>10.1093/eurheartj/ehad898</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38327005</guid>
<pubDate>Thu, 08 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Charo Bruce</dc:creator>
<dc:creator>Michael A Gatzoulis</dc:creator>
<dc:creator>Margarita Brida</dc:creator>
<dc:date>2024-02-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Digital technology and artificial intelligence for improving congenital heart disease care: alea iacta est</dc:title>
<dc:identifier>pmid:38327005</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad898</dc:identifier>
</item>
<item>
<title>Hypertension and the kidney: an update</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38326985/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 8:ehad896. doi: 10.1093/eurheartj/ehad896. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38326985/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38326985</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad896>10.1093/eurheartj/ehad896</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38326985</guid>
<pubDate>Thu, 08 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Luis M Ruilope</dc:creator>
<dc:creator>Alberto Ortiz</dc:creator>
<dc:creator>Gema Ruiz-Hurtado</dc:creator>
<dc:date>2024-02-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Hypertension and the kidney: an update</dc:title>
<dc:identifier>pmid:38326985</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad896</dc:identifier>
</item>
<item>
<title>Iron deficiency and supplementation in heart failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38326440/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>Non-anaemic iron deficiency (NAID) is a strategic target in cardiovascular medicine because of its association with a range of adverse effects in various conditions. Endeavours to tackle NAID in heart failure have yielded mixed results, exposing knowledge gaps in how best to define 'iron deficiency' and the handling of iron therapies by the body. To address these gaps, we harness the latest understanding of the mechanisms of iron homeostasis outside the erythron and integrate clinical and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Feb 7. doi: 10.1038/s41569-024-00988-1. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Non-anaemic iron deficiency (NAID) is a strategic target in cardiovascular medicine because of its association with a range of adverse effects in various conditions. Endeavours to tackle NAID in heart failure have yielded mixed results, exposing knowledge gaps in how best to define 'iron deficiency' and the handling of iron therapies by the body. To address these gaps, we harness the latest understanding of the mechanisms of iron homeostasis outside the erythron and integrate clinical and preclinical lines of evidence. The emerging picture is that current definitions of iron deficiency do not assimilate the multiple influences at play in patients with heart failure and, consequently, fail to identify those with a truly unmet need for iron. Additionally, current iron supplementation therapies benefit only certain patients with heart failure, reflecting differences in the nature of the unmet need for iron and the modifying effects of anaemia and inflammation on the handling of iron therapies by the body. Building on these insights, we identify untapped opportunities in the management of NAID, including the refinement of current approaches and the development of novel strategies. Lessons learned from NAID in cardiovascular disease could ultimately translate into benefits for patients with other chronic conditions such as chronic kidney disease, chronic obstructive pulmonary disease and cancer.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38326440/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38326440</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-00988-1>10.1038/s41569-024-00988-1</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38326440</guid>
<pubDate>Wed, 07 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Samira Lakhal-Littleton</dc:creator>
<dc:creator>John G F Cleland</dc:creator>
<dc:date>2024-02-07</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Iron deficiency and supplementation in heart failure</dc:title>
<dc:identifier>pmid:38326440</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-00988-1</dc:identifier>
</item>
<item>
<title>DYRK1A gene linked to heart defects in Down syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38326439/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Feb 7. doi: 10.1038/s41569-024-00995-2. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38326439/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38326439</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-00995-2>10.1038/s41569-024-00995-2</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38326439</guid>
<pubDate>Wed, 07 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Irene Fernández-Ruiz</dc:creator>
<dc:date>2024-02-07</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>DYRK1A gene linked to heart defects in Down syndrome</dc:title>
<dc:identifier>pmid:38326439</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-00995-2</dc:identifier>
</item>
<item>
<title>Reply: miRNAs, PICP, and Extent of Cardiac Damage in Patients With Fabry Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38325998/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 13;83(6):e59. doi: 10.1016/j.jacc.2023.11.031.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38325998/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38325998</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.11.031>10.1016/j.jacc.2023.11.031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38325998</guid>
<pubDate>Wed, 07 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Maria Chiara Meucci</dc:creator>
<dc:creator>Rosa Lillo</dc:creator>
<dc:creator>Francesca Graziani</dc:creator>
<dc:date>2024-02-07</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: miRNAs, PICP, and Extent of Cardiac Damage in Patients With Fabry Disease</dc:title>
<dc:identifier>pmid:38325998</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.11.031</dc:identifier>
</item>
<item>
<title>miRNAs, PICP, and Extent of Cardiac Damage in Patients With Fabry Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38325997/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 13;83(6):e57. doi: 10.1016/j.jacc.2023.10.052.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38325997/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38325997</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.10.052>10.1016/j.jacc.2023.10.052</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38325997</guid>
<pubDate>Wed, 07 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Salvatore Patanè</dc:creator>
<dc:creator>Roberto Licordari</dc:creator>
<dc:date>2024-02-07</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>miRNAs, PICP, and Extent of Cardiac Damage in Patients With Fabry Disease</dc:title>
<dc:identifier>pmid:38325997</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.10.052</dc:identifier>
</item>
<item>
<title>Measuring Absolute Coronary Flow and Microvascular Resistance by Thermodilution: JACC Review Topic of the Week</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38325996/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>Diagnosing coronary microvascular dysfunction remains challenging, primarily due to the lack of direct measurements of absolute coronary blood flow (Q) and microvascular resistance (R(μ)). However, there has been recent progress with the development and validation of continuous intracoronary thermodilution, which offers a simplified and validated approach for clinical use. This technique enables direct quantification of Q and R(μ), leading to precise and accurate evaluation of the coronary...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 13;83(6):699-709. doi: 10.1016/j.jacc.2023.12.014.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Diagnosing coronary microvascular dysfunction remains challenging, primarily due to the lack of direct measurements of absolute coronary blood flow (Q) and microvascular resistance (R<sub>μ</sub>). However, there has been recent progress with the development and validation of continuous intracoronary thermodilution, which offers a simplified and validated approach for clinical use. This technique enables direct quantification of Q and R<sub>μ</sub>, leading to precise and accurate evaluation of the coronary microcirculation. To ensure consistent and reliable results, it is crucial to follow a standardized protocol when performing continuous intracoronary thermodilution measurements. This document aims to summarize the principles of thermodilution-derived absolute coronary flow measurements and propose a standardized method for conducting these assessments. The proposed standardization serves as a guide to ensure the best practice of the method, enhancing the clinical assessment of the coronary microcirculation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38325996/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38325996</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.014>10.1016/j.jacc.2023.12.014</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38325996</guid>
<pubDate>Wed, 07 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Marta Belmonte</dc:creator>
<dc:creator>Emanuele Gallinoro</dc:creator>
<dc:creator>Nico H J Pijls</dc:creator>
<dc:creator>Dario Tino Bertolone</dc:creator>
<dc:creator>Danielle C J Keulards</dc:creator>
<dc:creator>Michele Mattia Viscusi</dc:creator>
<dc:creator>Tatyana Storozhenko</dc:creator>
<dc:creator>Takuya Mizukami</dc:creator>
<dc:creator>Thabo Mahendiran</dc:creator>
<dc:creator>Ruiko Seki</dc:creator>
<dc:creator>Stephane Fournier</dc:creator>
<dc:creator>Annemiek de Vos</dc:creator>
<dc:creator>Julien Adjedj</dc:creator>
<dc:creator>Emanuele Barbato</dc:creator>
<dc:creator>Jeroen Sonck</dc:creator>
<dc:creator>Peter Damman</dc:creator>
<dc:creator>Thomas Keeble</dc:creator>
<dc:creator>Samer Fawaz</dc:creator>
<dc:creator>Alejandro Gutiérrez-Barrios</dc:creator>
<dc:creator>Valeria Paradies</dc:creator>
<dc:creator>Frederic Bouisset</dc:creator>
<dc:creator>Morton J Kern</dc:creator>
<dc:creator>William F Fearon</dc:creator>
<dc:creator>Carlos Collet</dc:creator>
<dc:creator>Bernard De Bruyne</dc:creator>
<dc:date>2024-02-07</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Measuring Absolute Coronary Flow and Microvascular Resistance by Thermodilution: JACC Review Topic of the Week</dc:title>
<dc:identifier>pmid:38325996</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.014</dc:identifier>
</item>
<item>
<title>Implantable Hemodynamic-GUIDE Monitors: A CHAMPION Among Devices for Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38325995/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 13;83(6):695-698. doi: 10.1016/j.jacc.2023.12.008.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38325995/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38325995</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.008>10.1016/j.jacc.2023.12.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38325995</guid>
<pubDate>Wed, 07 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Marat Fudim</dc:creator>
<dc:creator>Javed Butler</dc:creator>
<dc:creator>Veraprapas Kittipibul</dc:creator>
<dc:date>2024-02-07</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Implantable Hemodynamic-GUIDE Monitors: A CHAMPION Among Devices for Heart Failure</dc:title>
<dc:identifier>pmid:38325995</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.008</dc:identifier>
</item>
<item>
<title>Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38325994/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>CONCLUSIONS: Management of patients with HFrEF using an implantable hemodynamic monitor significantly reduces both mortality and HF hospitalizations. The reduction in HF hospitalizations is seen early in the first year of monitoring and mortality benefits occur after the first year.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 13;83(6):682-694. doi: 10.1016/j.jacc.2023.11.030.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Trials evaluating implantable hemodynamic monitors to manage patients with heart failure (HF) have shown reductions in HF hospitalizations but not mortality. Prior meta-analyses assessing mortality have been limited in construct because of an absence of patient-level data, short-term follow-up duration, and evaluation across the combined spectrum of ejection fractions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The purpose of this meta-analysis was to determine whether management with implantable hemodynamic monitors reduces mortality in patients with heart failure and reduced ejection fraction (HFrEF) and to confirm the effect of hemodynamic-monitoring guided management on HF hospitalization reduction reported in previous studies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The patient-level pooled meta-analysis used 3 randomized studies (GUIDE-HF [Hemodynamic-Guided Management of Heart Failure], CHAMPION [CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients], and LAPTOP-HF [Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy]) of implantable hemodynamic monitors (2 measuring pulmonary artery pressures and 1 measuring left atrial pressure) to assess the effect on all-cause mortality and HF hospitalizations.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 1,350 patients with HFrEF were included. Hemodynamic-monitoring guided management significantly reduced overall mortality with an HR of 0.75 (95% CI: 0.57-0.99); P = 0.043. HF hospitalizations were significantly reduced with an HR of 0.64 (95% CI: 0.55-0.76); P &lt; 0.0001.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Management of patients with HFrEF using an implantable hemodynamic monitor significantly reduces both mortality and HF hospitalizations. The reduction in HF hospitalizations is seen early in the first year of monitoring and mortality benefits occur after the first year.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38325994/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38325994</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.11.030>10.1016/j.jacc.2023.11.030</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38325994</guid>
<pubDate>Wed, 07 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>JoAnn Lindenfeld</dc:creator>
<dc:creator>Maria Rosa Costanzo</dc:creator>
<dc:creator>Michael R Zile</dc:creator>
<dc:creator>Anique Ducharme</dc:creator>
<dc:creator>Richard Troughton</dc:creator>
<dc:creator>Alan Maisel</dc:creator>
<dc:creator>Mandeep R Mehra</dc:creator>
<dc:creator>Sara Paul</dc:creator>
<dc:creator>Samuel F Sears</dc:creator>
<dc:creator>Frank Smart</dc:creator>
<dc:creator>Nessa Johnson</dc:creator>
<dc:creator>John Henderson</dc:creator>
<dc:creator>Philip B Adamson</dc:creator>
<dc:creator>Akshay S Desai</dc:creator>
<dc:creator>William T Abraham</dc:creator>
<dc:creator>GUIDE-HF, CHAMPION, and LAPTOP-HF Investigators</dc:creator>
<dc:date>2024-02-07</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction</dc:title>
<dc:identifier>pmid:38325994</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.11.030</dc:identifier>
</item>
<item>
<title>Thrombosis, Bleeding, and the Promise of Factor XI(a) Inhibition</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38325993/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240212011100&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 13;83(6):679-681. doi: 10.1016/j.jacc.2023.12.003.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38325993/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240212011100&v=2.18.0">38325993</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.003>10.1016/j.jacc.2023.12.003</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38325993</guid>
<pubDate>Wed, 07 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Felicita Andreotti</dc:creator>
<dc:creator>Massimo Massetti</dc:creator>
<dc:creator>Gilles Montalescot</dc:creator>
<dc:date>2024-02-07</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Thrombosis, Bleeding, and the Promise of Factor XI(a) Inhibition</dc:title>
<dc:identifier>pmid:38325993</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.003</dc:identifier>
</item>





























</channel>
</rss>